News News
Media Bias Chart - New
Pricing & Services
Bias Meter
Tools
Semaglutide Follow
Being dangerously thin is back in. Is the body-positivity era officially over? | Arwa Mahdawi
Semaglutide
Being dangerously thin is back in. Is the body-positivity era officially over? | Arwa Mahdawi
The Guardian
Oct 12, 2024

Somewhat Conservative

...
View Bias Rating
Novo Nordisk faces US congressional grilling over price of weight loss drugs
Novo Nordisk
Novo Nordisk faces US congressional grilling over price of weight loss drugs
Financial Times
Sep 23, 2024

Somewhat Conservative

...
View Bias Rating
North Carolina chose to cover obesity drugs for its poor, but not its own employees
Semaglutide
North Carolina chose to cover obesity drugs for its poor, but not its own employees
WRAL
Sep 02, 2024

Medium Conservative

...
View Bias Rating
Biden hosts high-stakes NATO summit in Washington | The Excerpt
Semaglutide
Biden hosts high-stakes NATO summit in Washington | The Excerpt

Jul 09, 2024

Center

...
View Bias Rating
How Ozempic could save America's health system
Medication
How Ozempic could save America's health system
New York Post
Jul 06, 2024

Somewhat Conservative

...
View Bias Rating
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Eli Lilly
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Yahoo! Finance
May 26, 2024

Center

...
View Bias Rating
Why Now Is The Time To Reinvent Processed Foods
Ultra-processed food
Why Now Is The Time To Reinvent Processed Foods
Forbes
Mar 04, 2024

Center

...
View Bias Rating
Brouhaha over Oprah on Ozempic shows technology advances faster than attitudes
WW International
Brouhaha over Oprah on Ozempic shows technology advances faster than attitudes
The Guardian
Mar 02, 2024

Somewhat Liberal

...
View Bias Rating
Trump's sudden weight loss sparks health concerns as he 'skips meals'
Weight loss
Trump's sudden weight loss sparks health concerns as he 'skips meals'
Mirror
Jan 27, 2024

Center

...
View Bias Rating
Ozempic Maker's Obesity-Fueled Gains Seen Slowing After Banner Year
Weight loss
Ozempic Maker's Obesity-Fueled Gains Seen Slowing After Banner Year
Yahoo Finance
Dec 17, 2023

Somewhat Liberal

...
View Bias Rating
Opinion | Oprah is on Ozempic. Let the next phase begin.
United States Congress
Opinion | Oprah is on Ozempic. Let the next phase begin.
Washington Post
Dec 15, 2023

Center

...
View Bias Rating
Novo Nordisk: Yahoo Finance's Company of the Year
Weight loss
Novo Nordisk: Yahoo Finance's Company of the Year
Yahoo Finance
Dec 11, 2023

Somewhat Liberal

...
View Bias Rating
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk's Ozempic
Novo Nordisk
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk's Ozempic
MarketWatch
Dec 04, 2023

Center

...
View Bias Rating
Opinion | Good luck finding a 4 percent mortgage rate anytime soon
Semaglutide
Opinion | Good luck finding a 4 percent mortgage rate anytime soon
Washington Post
Nov 02, 2023

Center

...
View Bias Rating
How Novo Nordisk makes its weight-loss drug Wegovy
API
How Novo Nordisk makes its weight-loss drug Wegovy
Reuters
Nov 01, 2023

Center

...
View Bias Rating
View More